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 Abstract 33 
Objectives: 34 
Beside pathophysiological factors, pain is believed to play a crucial role in the progression of 35 
patellofemoral pain (PFP). However, the isolated effect of pain on biomechanics and 36 
quadriceps function has not been investigated in PFP. Thus, this study aimed to investigate the 37 
effect of pain on quadriceps function and lower limb biomechanics in individuals with PFP. 38 
Methods 39 
Twenty-one individuals with PFP (11 males and 10 females, age: 29.76 ±6.36 years, height: 40 
1.74 ± 0.09m, mass: 70.12 ±8.56kg) were measured at two different occasions: when not and 41 
when experiencing acute pain. Peak quadriceps torque (concentric, eccentric and isometric) 42 
and arthrogenic muscle inhibition (AMI) was assessed. Three-dimensional motion analysis and 43 
surface electromyography of the quadriceps and hamstrings muscles were collected during 44 
running, a single-leg-squat and step-down task. The normality was assessed using the Shapiro-45 
Wilk test and a MANOVA was performed at the 95% confidence interval.  46 
Results 47 
AMI increased significantly in acute pain. The net muscle activation of the knee extensors and 48 
flexors decreased during running in acute pain. The lower limb biomechanics and the 49 
quadriceps torque did not change in acute pain.  50 
Discussion: 51 
It appears that even if individuals with PFP experience pain they can still deliver maximal 52 
quadriceps contractions and maintain their moving patterns without biomechanical changes. 53 
However, the overall reduced activation of the quadriceps and the increased AMI indicate the 54 
presence of quadriceps inhibition in acute pain.  55 
Key words: patellofemoral pain, knee, PFP, AKP, inhibition, quadriceps, strength, pain  56 
 1. Introduction 57 
Patellofemoral pain (PFP) is commonly diagnosed in individuals with knee injuries and often 58 
affects younger and active populations [1]. Follow-up studies showed that the majority of 59 
individuals with PFP still suffered from pain and dysfunction, despite initially received 60 
treatment and education; Lankhorst et al. reported an unfavourable recovery at 5 to 8 years of 61 
57% of individuals with PFP [2] and Stathopulu & Baildam found that 91% of patients still 62 
suffered from PFP 4-18 years after their initial presentation at a hospital [3]. Thus, the long-63 
term prognosis of PFP is still poor, which raises the question whether the pathophysiological 64 
factors that cause PFP are understood and addressed in treatments sufficiently. Currently, 65 
pathophysiological factors associated with PFP can be compared with a complex mosaic where 66 
various anatomical, biomechanical, psychological and social factors are interconnected to each 67 
other and are likely to contribute to pain [4]. Long-term studies showed that individuals with 68 
PFP with greater durations of pain and worse pain were more likely to develop an unfavourable 69 
outcome and a more progressive pathology [5, 6]. Thus, it is believed that pain might play a 70 
role in the aetiology and progression of PFP [7].  71 
Previous studies have reported a link between PFP and lower limb muscle weakness and 72 
inhibition, knee instability, and functional performance [8-10]. However, all studies either 73 
correlated the pain intensity to specific factors or based their findings on the comparison of the 74 
pain intensity before and after a treatment. The only studies that investigated the direct 75 
influence of acute knee pain on muscular function and lower limb biomechanics analysed the 76 
effect of artificially induced knee pain [11-14]. These studies demonstrate a link of pain to 77 
several factors, such as alterations of lower limb biomechanics, muscular coordination, 78 
quadriceps strength and arthrogenic muscle inhibition (AMI). AMI describes an ongoing reflex 79 
response which results in an inability to completely contract a muscle voluntarily, despite no 80 
structural damage to the muscle or innervating nerve [15, 16]. AMI is closely linked to knee 81 
pain, because it is caused by altered afferent input originating from mechanoreceptors and 82 
nociceptors, which reflexively reduce the efferent quadriceps alpha motor-neuron output [16, 83 
17].  However, the isolated effect of pain in individuals with PFP has not been investigated. 84 
Individuals with PFP commonly show altered movement patterns and aberrant muscle function 85 
[4], but it remains unclear whether these changes are consequence of pain or are causal factors 86 
in the development of PFP. It also remains unknown to what extent acute pain would influence 87 
the functional performance and muscular function in individuals with PFP. A better 88 
 understanding of the influence of pain in individuals with PFP would provide further insights 89 
into PFP that might help to optimise management and treatment of PFP. Therefore, this study 90 
aimed to investigate the direct effect of acute PFP on quadriceps strength and AMI, quadriceps 91 
and hamstrings co-contraction and hip and knee biomechanics. 92 
 93 
2. Methods 94 
The study was approved by the University of Salford Research and Governance Committee 95 
(HSR 15-143) and the trial was registered at ClinicalTrials.gov (NCT02914574). The informed 96 
consent was obtained from each participant. Posters and flyers at fitness centres, gyms, and 97 
sports clubs in Manchester and Salford were used to recruit participants with PFP and without 98 
PFP. 99 
 100 
2.1. Participants 101 
The inclusion and exclusion criteria, as well as the clinical assessment were developed based 102 
on current recommendations [18]. The inclusion criteria for participants with PFP were: (1) 103 
aged 18-45 years (to exclude patients with knee or patellar osteoarthritis); (2) antero- or retro-104 
patellar pain with at least two of these activities: ascending or descending stairs or ramps, 105 
squatting, kneeling, prolonged sitting, hopping/ jumping, isometric quadriceps contraction or 106 
running (3) duration of current PFP symptoms >1 month 107 
The exclusion criteria were: (1) any history of previous lower limb surgery or patella instability 108 
and dislocation, (2) lower limb deformities or any history of traumatic, inflammatory or 109 
infectious pathology in the lower extremities or any internal derangements, (3) not able to 110 
perform running, squatting and the step-down task during the measurement. (4) Those who 111 
failed to satisfy the above listed inclusion criteria.  112 
Since there is no definite clinical test to diagnose PFP, further clinical assessment were carried 113 
out, which involved the Clarke’s test, a palpation test of the patellar edges and a single leg 114 
squat task to investigate the pain region [18]. These three tests have been chosen based on the 115 
current recommendations and have shown to provide limited to good diagnostic evidence [18]. 116 
All clinical assessments were performed by the same experienced musculoskeletal 117 
 physiotherapist. All participants were fitted with standard running shoes (New Balance, model 118 
M639SA UK), to control the interface of the shoe and the surface. 119 
The participants were asked to attend the first appointment whilst not experiencing pain and 120 
the second appointment whilst experiencing acute pain. This order was set to ensure, that the 121 
participants had time to raise questions and concerns during the first visit, before they 122 
performed the exercises that triggered their acute PFP. Both measurement sessions were 123 
scheduled within one week. The participants were instructed to perform exercises before the 124 
second appointment which they were familiar with and were sure would trigger their acute 125 
PFP. Since the participants performed the exercises independently between the first and second 126 
assessment, the researchers were unable to control the exercises. However, the researcher 127 
documented the form of exercises the participants had chosen; Twelve participants chose 128 
running and 9 participants chose eccentric quadriceps exercises (in particular lunges and 129 
squats) to trigger the acute PFP. The pain intensity was reported but participants were not 130 
instructed to self-inflict their acute pain up to a specific pain intensity level. Instead the 131 
participants were instructed to self-inflict the pain to the extent that they experienced as their 132 
familiar acute PFP. To ensure that they were not fatigued they were asked to not perform the 133 
painful activity at least 5 hours before coming to the second appointment and were advised to 134 
rest before arriving at the gait laboratory.  135 
 136 
2.2. 3D movement analysis 137 
Three-dimensional motion data were collected with ten Qualisys OQUS7 cameras (Qualisys 138 
AB, Sweden) at a sampling rate of 250Hz. Three force plates (BP600900, Advanced 139 
Mechanical Technology, Inc. USA) were used to collect the force data at a sampling rate of 140 
1500Hz. The calibrated anatomical system technique (CAST) model, which included 141 
anatomical landmarks (markers on anatomical bony landmarks) and anatomical frames 142 
(segment mounted marker clusters), was used in the biomechanical modelling and analysis 143 
[19]. Retroflective markers were placed, with double sided hypoallergic tape to the following 144 
anatomical landmarks of both lower limbs of the participant: the anterior superior iliac spine 145 
(ASIS), the posterior superior iliac spine (PSIS), the iliac crest, the greater trochanter, the 146 
medial and lateral femoral epicondyle, the medial and lateral malleoli, the posterior calcanei, 147 
and the head of the first, second and fifth metatarsals. The anatomical frames were rigid clusters 148 
 of 4 nonorthogonal markers and were positioned over the lateral shank, and the lateral thigh of 149 
the limbs (Figure 1) [19].  150 
For the electrode placement of the surface Electromyography (sEMG), the skin was shaved, 151 
abraded and cleaned with isopropyl alcohol. The sEMG electrodes (Noraxon Dual Electrodes, 152 
2cm spacing) were placed on the vastus medialis, vastus lateralis, biceps femoris and 153 
semitendinosus muscle in accordance with the SENIAM guidelines [20]. The sEMG data were 154 
collected with the Noraxon Telemyo system at a sampling rate of 1500Hz. The sEMG data 155 
were synchronised to the kinematic and kinetic data.  156 
All participants were measured at one occasion without acute pain or only very light pain and 157 
at the second occasion while the participant experienced acute pain. The participants were 158 
asked on both occasions to rate their pain intensity using the numeric pain rating scale (NPRS) 159 
after performing the biomechanical tasks. To investigate whether the application of the 3D 160 
markers and bandages modified the pain, each participant was asked to rank his/her pain 161 
intensity with and without the applied bandages and markers. Each subject was asked at both 162 
occasions to perform a static trial and to run on a 15m walkway at a self-selected speed. 163 
Running speed was measured and reported by using Brower timing lights (Draper, UT). The 164 
participant was asked to perform a single leg squat and a step-down test while holding his/her 165 
arms folded across his/her chest. Both tasks were demonstrated and explained by the 166 
researcher. Each task was performed until five successful trials were collected. Unsuccessful 167 
trials were ones whereby less than three markers per segment were visible or a partial/double 168 
foot contact with one of the force platforms happened.  169 
   170 
Figure 1: The placement of the markers and the sEMG electrodes 171 
 172 
2.3. Quadriceps strength and inhibition analysis 173 
At both occasions each subject was asked to perform three times the following knee extensor 174 
strength tests: an isometric, an eccentric and a concentric test. The peak torque was measured 175 
with an isokinetic dynamometer (Kin-Com, Chattanooga, USA). Participants were positioned 176 
in 90° hip flexion and 60° knee flexion in an isokinetic dynamometer and secured to the test 177 
chair with a chest and pelvic belt. The Kin-Com shin pad was attached 1 cm proximal to the 178 
malleoli of the ankle (Figure 2). The isokinetic knee extensor torque measurements were tested 179 
at the angular velocity of 60 degrees/second. The participants were advised to keep their arms 180 
across their chest.  181 
The muscular inhibition of the quadriceps was assessed, during a maximal voluntary isometric 182 
contraction (MVIC) of the quadriceps with the interpolated twitch technique, using a single 183 
twitch with a pulse duration of 200 ms and a stimulus amplitude of 125mA (DS7AH Digitimer 184 
Ltd, Hertfordshire, England). Two electrodes (proximal: 50×130 mm, distal: 7.5×100 mm) 185 
(Axelgaard, Fallbrook, Ca, USA) were placed on the quadriceps muscle at one-third and two-186 
 thirds from the distance between the anterior superior iliac spine and the upper border of the 187 
patella [21].  188 
Prior to the test a warm-up session of 4 submaximal isometric and isokinetic quadriceps 189 
contractions were performed. The submaximal testing at around 50% of the participants MVIC 190 
was chosen to ensure that the participant was warmed up and familiarised with the 191 
measurement without feeling fatigued.  After the warm-up a familiarisation of the stimulation 192 
sensation was made with several test stimuli. Prior to the isometric MVIC two single twitches 193 
of 125 mA were triggered by the assessor on the relaxed quadriceps. During the MVIC attempt 194 
two single pulses of 200µs duration, 200Volt and 125 mA were triggered by the investigator 195 
when the MVIC force had plateaued on the monitor. The strength data and AMI data of each 196 
participant was exported from the Kin-Com to asci-files and loaded into Excel. The peak 197 
concentric, eccentric and isometric torque was determined for each file. AMI was quantified 198 
by calculating the difference between the stimulus-evoked torque during MVIC (ITT in Nm) 199 
to the stimulus-evoked torque at rest (RTT in Nm) and expressed in %: activation deficit (AD) 200 
at 100% MVIC from the ratio: AD = (ITT/RTT) x 100. An inhibition of 0% means that the 201 
subject was able to fully recruit the muscle without showing any signs of inhibition.  202 
 203 
Figure 2: Knee extensor strength and quadriceps arthrogenic muscle inhibition measurement 204 
 205 
 2.4. Processing of 3D motion data 206 
The kinematic and kinetic outcomes were calculated using a 6 degrees of freedom model in 207 
Visual3D (Version 5, C-motion Inc., USA). The pelvis, thigh, shank, foot and virtual foot 208 
segments were defined and 4 tracking markers were used for each segment. Ankle and knee 209 
joint centers were calculated as midpoints between the malleoli and femoral epicondyles 210 
respectively and the hip joint center was calculated using the regression model of Bell et al. 211 
[22] based on the ASIS and PSIS markers. The global coordinate system was defined as x for 212 
the forward/ backward, z the vertical and y the left/ right (medial/ lateral) axis. Marker motion 213 
data and the analogue data from the force plate were filtered with a 4th order lowpass 214 
Butterworth filter with cut-off frequencies of 12Hz. The joint moments were calculated using 215 
three dimensional inverse dynamics and normalised to body mass. The kinematic and kinetic 216 
data were normalised to 100% of a single leg squat, a step-down task and the stance phase in 217 
running, whereby the stance phase was sub-grouped in early (0-24% of stance phase), mid (25-218 
62%) and late-stance phase (63%-100%) [23]. The peaks of the hip and knee flexion, adduction 219 
and internal rotation angles and the moments were calculated for the single leg squat, step-220 
down task and the early, mid and late-stance phase. Furthermore, the average knee angular 221 
velocity was calculated for the eccentric phase during the single leg squat and step-down task.  222 
 223 
2.5. Processing of sEMG data 224 
The sEMG data was band-pass filtered at 20-500 Hz and rectified by using a root mean square 225 
over a 75 ms window for the running task and 300 ms for the single leg squat and step-down 226 
task [24]. Co-contraction ratios were (CCR) calculated by using the formula of Heiden et al.:  227 
If agonist mean EMG > antagonistic mean EMG:  228 
 CCR= 1- antagonistic mean EMG/agonist mean EMG 229 
If agonist mean EMG < antagonistic mean EMG: 230 
 CCR= agonist mean EMG/ antagonistic mean EMG -1 [25] 231 
The peak quadriceps torque was determined for each file and AMI was calculated during the 232 
isometric contraction.  233 
 234 
 2.6. Statistical analysis 235 
The statistical analysis was performed using SPSS (v. 20, IBM, USA) and Excel 2013 236 
(Microsoft, USA). The normality was assessed by applying the Shapiro-Wilk test and by the 237 
investigation of the normal q-q plots. The Wilcoxon rank test was used with a significance 238 
level set at p<0.05 to investigate the ordinal data (pain scale). 239 
Kinematic and kinetic variables, quadriceps strength, quadriceps AMI and co-contraction ratios 240 
were compared between the two conditions: with and without acute pain using a one way 241 
repeated measures MANOVA. The standard error of mean (SEM) was calculated using the 242 
following formula: SEM = SD/√sample size. The effect size for each variable was calculated 243 
using the Cohen d to give an indication of the magnitude of the effect of acute pain (>0.8 244 
large effect, 0.5 moderate effect, <0.3 small effect) [26]. 245 
 246 
3. Results 247 
Twenty-one individuals with PFP (11 males and 10 females, age: 29.76 ±6.36 years, height: 248 
1.74 ± 0.09m, mass: 70.12 ±8.56kg) participated in the study. The running speed without and 249 
with pain was not significantly different (p=0.608) (without pain: 3.32±0.71m/s, with pain: 3.4 250 
±0.15m/s).  251 
The application of the bandage and the markers did not result in significant changes in pain 252 
under both test conditions (NPRS: baseline pain: without marker application: 1.29±1.95; with 253 
application: 1.17±1.95,p=0.582, acute pain: without application: 3.88±1.92; with application: 254 
3.86±1.96,p=0.902). Pain was significantly increased when participants performed the tasks 255 
with acute pain (with and without pain: p=0.0001). A clinically significant change in pain has 256 
been described as 1.74 points, thus the pain increase by 2.59 represents a clinical meaningful 257 
increase in pain [27]. 258 
Only during the late-stance phase in running the external knee flexion moment significantly 259 
decreased with a moderate effect size in acute pain (p=0.042) (Table 2). Although the change 260 
was not significant a moderate effect size indicated also a reduction of the external knee flexion 261 
moment during the mid-stance phase.  262 
 The net activation of the knee extensors and flexors decreased significantly during the early 263 
and mid-stance phase with medium to large effect sizes (quadriceps: 32.2% reduction, p=0.025, 264 
hamstrings: 11.4% reduction, p=0.008) in acute pain (Table 3).  265 
The peak isometric, concentric and eccentric torque did not change with or without acute pain 266 
(Table 4). However, the AMI increased significantly in acute pain with a moderate effect size 267 
(6.56% increase, p=0.035) (Table 4).   268 
 Table 1: The lower extremity kinematics during the single leg squat task and the step-down task with and 269 
without acute pain (*indicated the results were significantly different.) 270 
The kinematic variables (º) during the single 
leg squat and step-down task 
Without pain With acute pain P value: 
(T-test, 
sig 2-
tailed) 
Effect 
size Mean SD 
Std. 
Error 
Mean 
Mean SD 
Std. 
Error 
Mean 
Single 
leg 
squat  
Hip flexion angle 75.7 15.6 3.4 76.9 16.4 3.6 0.813 0.08 
Hip adduction angle 14.5 7 1.5 13.6 7.6 1.7 0.697 0.08 
Hip internal rotation angle  1.9 7.5 1.6 0.7 7.8 1.7 0.607 0.16 
Knee flexion angle 81.1 9.3 2 81.9 10.7 2.3 0.786 0.08 
Knee adduction angle 5.3 4.7 1 4.2 4.5 1 0.460 0.24 
Knee internal rotation angle -2.5 6.3 1.4 -1.5 5.9 1.3 0.575 0.16 
Step-
down 
task 
Hip flexion angle 71.8 18.2 4 74.5 15 3.3 0.608 0.16 
Hip adduction angle 16.4 6.7 1.5 15.7 6.7 1.5 0.717 0.10 
Hip internal rotation angle  2.2 6.8 1.5 0.6 7.6 1.7 0.485 0.22 
Knee flexion angle 89.4 14 3.1 90.3 13 2.8 0.842 0.07 
Knee adduction angle 5.4 4.4 1 4.5 4.6 1 0.508 0.2 
Knee internal rotation angle -1.1 6.5 1.4 -1.1 6.1 1.3 0.977 0 
Early-
stance 
phase  
Hip flexion angle 36.5 5.9 1.3 36.8 5.5 1.2 0.835 0.05 
Hip adduction angle 7.1 4.6 1 6.7 4.8 1.1 0.746 0.09 
Hip internal rotation angle  2.9 7.9 1.7 3.4 7.4 1.6 0.895 0.07 
Knee flexion angle 30.6 3.9 0.9 31.6 4 0.9 0.460 0.25 
Knee adduction angle 2.2 3.4 0.7 2.5 3.9 0.8 0.779 0.08 
Knee internal rotation angle -4.8 5.9 1.3 -3.9 5.2 1.1 0.373 0.18 
Mid-
stance 
phase 
Hip flexion angle 34.6 6.5 1.4 34.9 5.9 1.3 0.946 0.05 
Hip adduction angle 11.5 4.8 1 10.1 5.3 1.2 0.387 0.28 
Hip internal rotation angle  -0.1 7.5 1.6 -0.9 8.7 1.9 0.908 0.10 
Knee flexion angle 43.3 5 1.1 44.6 5 1.1 0.824 0.26 
Knee adduction angle 1.7 3.3 0.7 0.9 4.8 1 0.784 0.19 
Knee internal rotation angle 1 6.3 1.4 1.2 5.5 1.2 0.783 0.03 
Late-
stance 
phase 
Hip flexion angle 21.1 5.7 1.2 21 5.2 1.1 0.856 0.18 
Hip adduction angle 7.2 5 1.1 7 4.9 1.1 0.279 0.04 
Hip internal rotation angle  1.1 7.4 1.6 0.2 9.2 2 0.594 0.11 
Knee flexion angle 40.9 4 0.9 41.7 4.6 1 0.441 0.19 
Knee adduction angle 1.2 2.7 0.6 1.1 3.8 0.8 0.514 0.03 
Knee internal rotation angle 0 7.1 1.5 0.6 5.4 1.2 0.651 0.10 
  271 
 Table 2: The lower extremity kinetics during the single leg squat task and the step-down task with and 272 
without acute pain (*indicated the results were significantly different.) 273 
The kinetic variables (Nm/kg) during the 
single leg squat and step-down task 
Without pain With acute pain P value: 
(T-test, 
sig 2-
tailed) 
Effect 
size Mean SD 
Std. 
Error 
Mean 
Mean SD 
Std. 
Error 
Mean 
Single 
leg 
squat  
Hip flexion moment 1.29 0.55 0.12 1.34 0.55 0.12 0.790 0.09 
Hip adduction moment 0.95 0.28 0.06 0.91 0.2 0.04 0.636 0.16 
Hip internal rotation moment -0.14 0.05 0.01 -0.15 0.07 0.02 0.619 0.16 
Knee flexion moment 1.74 0.41 0.09 1.67 0.28 0.06 0.556 0.20 
Knee adduction moment 0.33 0.12 0.03 0.3 0.11 0.02 0.421 0.26 
Knee internal rotation moment 0.4 0.09 0.02 0.37 0.09 0.02 0.350 0.33 
Step-
down 
task 
Hip flexion moment 1.49 0.72 0.16 1.58 0.69 0.15 0.690 0.13 
Hip adduction moment 1.13 0.27 0.06 1.06 0.2 0.04 0.387 0.29 
Hip internal rotation moment -0.1 0.07 0.02 -0.12 0.06 0.01 0.405 0.31 
Knee flexion moment 1.74 0.35 0.08 1.69 0.29 0.06 0.594 0.16 
Knee adduction moment 0.39 0.18 0.04 0.35 0.14 0.03 0.475 0.25 
Knee internal rotation moment 0.4 0.09 0.02 0.37 0.09 0.02 0.252 0.33 
Early-
stance 
phase  
Hip flexion moment 2.03 0.42 0.09 1.99 0.4 0.09 0.545 0.10 
Hip adduction moment 1.24 0.45 0.1 1.08 0.33 0.07 0.396 0.41 
Hip internal rotation moment 0.05 0.12 0.03 0.06 0.09 0.02 0.946 0.09 
Knee flexion moment 1.42 0.48 0.11 1.38 0.33 0.07 0.060 0.10 
Knee adduction moment 0.52 0.28 0.06 0.45 0.26 0.06 0.576 0.26 
Knee internal rotation moment 0.22 0.1 0.02 0.2 0.11 0.02 0.648 0.19 
Mid-
stance 
phase 
Hip flexion moment 0.94 0.59 0.13 0.87 0.42 0.09 0.986 0.14 
Hip adduction moment 1.95 0.42 0.09 1.82 0.47 0.1 0.710 0.29 
Hip internal rotation moment -0.26 0.17 0.04 -0.26 0.17 0.04 0.523 0 
Knee flexion moment 2.89 0.72 0.16 2.48 0.77 0.17 0.078 0.55 
Knee adduction moment 0.55 0.29 0.06 0.5 0.3 0.07 0.918 0.17 
Knee internal rotation moment 0.44 0.14 0.03 0.41 0.15 0.03 0.764 0.21 
Late-
stance 
phase 
Hip flexion moment -0.03 0.28 0.06 0.02 0.26 0.06 0.540 0.19 
Hip adduction moment 1.43 0.42 0.09 1.37 0.46 0.1 0.680 0.14 
Hip internal rotation moment 0.02 0.03 0.01 0.02 0.04 0.01 0.778 0 
Knee flexion moment 1.96 0.51 0.11 1.68 0.51 0.11 0.042* 0.55 
Knee adduction moment 0.36 0.21 0.05 0.33 0.21 0.05 0.742 0.14 
Knee internal rotation moment 0.25 0.11 0.02 0.23 0.11 0.02 0.600 0.19 
  274 
 Table 3: Co-contraction ratio, net activation of the knee flexors and knee extensors during the stance phase 275 
in running, the single leg squat task and the step-down task with and without acute pain, (*indicated the 276 
results were significantly different.) 277 
 
Without pain With acute pain P value: 
(T-test, 
sig 2-
tailed) 
Effect 
size Mean SD 
Std. 
Error 
Mean 
Mean SD 
Std. 
Error 
Mean 
Single 
leg 
squat 
Co-contraction ratio (knee ext: knee flx.) 0.6 0.28 0.07 0.65 0.19 0.05 0.331 0.20 
Net activation knee extensors in % 74.97 36.65 8.64 52.95 35.32 8.32 0.177 0.61 
Net activation knee flexors in % 28.81 16.93 3.99 18.83 14.78 3.48 0.075 0.63 
Step-
down 
task 
Co-contraction ratio (knee ext: knee flx.) 0.58 0.29 0.07 0.63 0.23 0.05 0.688 0.19 
Net activation knee extensors in % 72.43 30.6 7.21 52.81 36.72 8.66 0.283 0.58 
Net activation knee flexors in % 30.55 20.7 4.88 19.29 14.74 3.47 0.183 0.63 
Early-
stance 
phase 
Co-contraction ratio (knee ext: knee flx.) 0.66 0.15 0.04 0.72 0.13 0.03 0.558 0.43 
Net activation knee extensors in % 134.49 67 15.79 102.29 59.11 13.93 0.025* 0.51 
Net activation knee flexors in % 38.26 17.91 4.22 26.86 17.99 4.24 0.008* 0.64 
Mid-
stance 
phase 
Co-contraction ratio (knee ext: knee flx.) 0.32 0.24 0.06 0.41 0.25 0.06 0.882 0.37 
Net activation knee extensors in % 81.74 41.9 9.88 63.16 35.75 8.43 0.010* 0.48 
Net activation knee flexors in % 50.21 21.43 5.05 33.29 19.61 4.62 0.002* 0.82 
Late-
stance 
phase 
Co-contraction ratio (knee ext: knee flx.) -0.44 0.47 0.11 -0.33 0.44 0.1 0.117 0.24 
Net activation knee extensors in % 6.76 5.67 1.34 8.9 16.29 3.84 0.928 0.18 
Net activation knee flexors in % 20.03 15.55 3.67 14.05 10.98 2.59 0.096 0.44 
 278 
Table 4: Strength, AMI, time to peak, rate to force development and the break phenomenon with and 279 
without acute pain. (*indicated the results were significantly different.) 280 
 
Without pain With acute pain P value: 
(T-test, 
sig 2-
tailed) 
Effect 
size Mean SD 
Std. 
Error 
Mean 
Mean SD 
Std. 
Error 
Mean 
Isometric quadriceps strength (Nm/kg*100) 2.86 0.76 0.17 2.90 1.26 0.27 0.889 0.04 
Eccentric quadriceps strength (Nm/kg*100) 3.14 1.40 0.30 2.74 0.69 0.15 0.249 0.36 
Concentric quadriceps strength (Nm/kg*100) 1.74 0.71 0.15 1.88 0.57 0.12 0.480 0.22 
AMI in % 10.58 9.33 2.04 17.14 12.71 2.77 0.035* 0.59 
 281 
4. Discussion 282 
To the authors’ knowledge, this is the first study to investigate the direct influence of acute 283 
pain on hip and knee biomechanics, quadriceps and hamstrings activation and quadriceps 284 
strength and AMI in individuals with PFP. This study showed that despite acute pain, hip and 285 
knee kinematics were not significantly changed. However, the external knee flexion moment 286 
was slightly decreased in acute pain during the mid- and late-stance phase in running, which is 287 
in accordance with previous studies demonstrating that artificially induced knee pain resulted 288 
in a decreased knee flexion moment [11, 12]. A reduced knee flexion moment is believed to be 289 
caused by the quadriceps avoidance strategy, which is a compensatory strategy to decrease 290 
joint loading and thereby joint pain [28]. This assumption could be supported by the findings 291 
 of a significantly increased quadriceps inhibition, decreased quadriceps activation and the 292 
slight decrease in the knee flexor moment. The simultaneously reduced activation of the 293 
quadriceps and hamstrings muscles has been previously described in individuals with artificial 294 
induced pain [12, 13].  295 
A balanced co-contraction of the quadriceps and hamstrings activation might assist in knee 296 
joint stabilisation in the frontal plane due to increased joint compression [29]. Thus, the overall 297 
reduced co-contraction of the quadriceps and hamstrings muscles might result in knee 298 
instability during the loading response and thus also might be responsible for the development 299 
of pain and the greater reduction and variability of the knee flexion moment [12, 13].  However, 300 
the reduced quadriceps muscle activation could also be a compensatory strategy to reduce 301 
patellofemoral joint reaction forces during painful activities, which has been described in 302 
literature as the quadriceps avoidance strategy.  303 
The quadriceps avoidance strategy is believed to be often caused by quadriceps inhibition [12, 304 
13, 30]. Rice et al. described that the inhibitory response of the quadriceps occurs partially due 305 
to spinal reflex inhibition of the alpha-motor-neuron (MN) [31]. This reflex inhibition is 306 
modulated by the pre- and postsynaptic mechanism and elicited by abnormal afferents from a 307 
painful or damaged joint [21, 32]. Thereby the painful or damaged joint causes a decreased 308 
motor drive to muscles and thus a limited muscle's potential to generate force [21]. Studies 309 
which investigated the association of pain to AMI found that it was significantly associated to 310 
knee pain [16, 21, 33] and that already 1 point increase on the visual analogue pain scale (VAS) 311 
caused an increase in AMI of 1.6% [21]. These findings are in accordance with the results of 312 
this study, where the pain increase of 1 on the NPRS caused an increase of 2.1% AMI. Thus, 313 
AMI appears to play an important role in the injury cycle of knee pain.  314 
Previous studies suggested an increase of the voluntary antagonist neural drive to overcome 315 
any inhibitory contractions [30, 33]. In contrary, this study showed that pain caused a decrease 316 
of the antagonistic muscles and thus indicates that not only the quadriceps, but also the 317 
hamstrings muscles might be inhibited due to pain [14]. This suggests that pain suppressed the 318 
motor output globally. But despite the significant altered muscle activation of the quadriceps 319 
and the hamstrings muscle, no significant biomechanical changes or differences in the maximal 320 
voluntary quadriceps contraction could be identified. Knee pain may be caused by a number of 321 
structures, such as the infrapatellar fat pad with its nociceptive innervations [34]. Previous 322 
studies have shown that knee pain, that was artificially induced in the quadriceps muscle or the 323 
 infrapatellar fat pad altered the coordination of the quadriceps muscle [12, 13, 35]. These 324 
studies showed that pain caused a reduced activation and altered activation timing of the 325 
quadriceps muscle, which is in accordance to our findings.  326 
In contrary to our findings, previous studies have shown that pain also resulted in a decrease 327 
of quadriceps strength [14, 33, 36]. However, these results were shown in healthy individuals 328 
with artificially induced knee pain. Individuals with PFP experience knee pain frequently and 329 
thus might show a different physical reaction to pain. Furthermore, in comparison to strength 330 
results of individuals with PFP in previous studies the participants in this study appeared to 331 
belong to a strong subgroup of individuals with PFP. Selfe et al. described three subgroups of 332 
patients with PFP; a "strong subgroup" with high quadriceps and hip abductor strength scores, 333 
a "weak and tight subgroup" with weak quadriceps and hip abductor muscles and low muscle 334 
flexibility and a "weak and pronated foot subgroup" with weak quadriceps and hip abductor 335 
muscles, greater patellar mobility and an increased foot pronation [37]. The strong subgroup 336 
had quadriceps torque scores of 1.65 ±0.53 Nm/kg in comparison with the weak groups with 337 
quadriceps torque values of 0.84 ±0.32 Nm/kg and 0.82 ±0.32Nm/kg. The group of individuals 338 
with PFP who participated in this study were highly active and had an isometric quadriceps 339 
strength score of: 2.86 ±0.76 Nm/kg without acute pain and with acute pain of 2.9 ±1.26 340 
Nm/kg. These results demonstrate that participants with PFP that participated in this study were 341 
stronger than previously reported in literature. The good training status of the participants with 342 
PFP might have enabled them to deliver maximal quadriceps contractions and maintain their 343 
moving patterns without biomechanical changes even when they experienced more pain and 344 
had a presence of AMI. However, research on strong individuals with PFP is still lacking and 345 
thus further research is needed to confirm these findings [37]. 346 
 347 
2. Clinical implications 348 
These results indicate that quadriceps AMI appears to be a crucial factor in acute PFP. AMI is 349 
present in a wide range of knee joint pathologies and described as a reflexive "shut-down" of 350 
the quadriceps muscle [16]. Immediately after knee injuries a decreased voluntary quadriceps 351 
activation is believed to be a protective mechanism to prevent further injuries [38]. However, 352 
quadriceps AMI may persist for a long time after the original injury and can lead to 353 
posttraumatic weakness and muscle atrophy [39]. Thereby it can become a limitation during 354 
rehabilitation [16, 39]. Thus, it is important for clinicians to identify AMI and to devise a 355 
 strategy to overcome this impairment [40]. Traditional strengthening exercises have 356 
demonstrated no effect on quadriceps AMI [38]. Although treatments, such as transcutaneous 357 
electrical nerve stimulation (TENS) have shown to have strong effects to reduce AMI they are 358 
not implemented in recommended physical interventions [38, 41]. Thus, a successful 359 
identification of AMI in individuals with PFP might be an important for clinicians to be able 360 
to apply an adequate treatment scheme. 361 
 362 
5. Limitations  363 
One limitation of this study was that pain caused by activities could not be monitored and 364 
standardised. The participants performed their familiar functional activities to reproduce the 365 
pain condition, which was not quantified and controlled. This study aimed to reproduce the 366 
acute PFP that these individuals experience during their familiar and functional and sports 367 
activities. Thus, the test procedure did not allow us to reproduce the individual familiar sport 368 
environment of each participant and to monitor and standardise the painful activities.  369 
It is important to note that the participants wore a pair of standard training shoes to control the 370 
shoe-surface interface and to minimise the influence of footwear in the study. The standard 371 
training shoes might have negatively influenced the comfort during running and thereby might 372 
have influenced their biomechanical performances.  373 
 374 
6. Conclusions 375 
To the authors knowledge this was the first study investigating the effect of acute pain on lower 376 
limb biomechanics, AMI and strength. Acute PFP pain caused a decrease of muscular activity 377 
of the quadriceps and hamstrings muscles and resulted in an increase of AMI of the quadriceps. 378 
However, acute pain did not alter biomechanical changes or quadriceps torque. These findings 379 
show that AMI appears to be an important factor that is linked to pain in individuals with PFP, 380 
which needs to be addressed appropriately in the treatment scheme. 381 
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